GAN Has Officially Gone Public On The Nasdaq

• GAN stocks are now available for trade on the Nasdaq.
• The company’s stocks will no longer be traded on AIM, the London based stock market.
• GAN is one of the many sportsbook technology providers in the United States.

NEW YORK – This week, sportsbook technology provider GAN has officially gone public, and now their stocks are available for trade.

Despite the ongoing COVID-19 (coronavirus) pandemic, legal sports betting is making a number of strides in the United States. Sports bets may be at an all-time low, but sports betting businesses are continuing to look towards the future.

Sports Betting Going Public

For sportsbooks to operate, casinos and other locations need to partner with a sports betting provider. Sportsbook providers give the businesses the technology they need to actually operate a sportsbook. That is what GAN does and has done in the United States.

Because of their new roots in the U.S., GAN has decided that it was time to go public in the U.S. stock market. Previously, GAN was publicly traded in AIM, the London based stock trading market.

Now GAN stocks are available to trade on the Nasdaq. So far, GAN has seen some success in its short time on the Nasdaq.

“GAN Limited, a leading business-to-business supplier of internet gambling software-as-a-service solutions primarily to the US land-based casino industry, today announced the pricing of its up-sized initial public offering of 6,380,000 ordinary shares at a price to the public of $8.50 per share,” said an investor report.

GAN is not the only sports betting company that has gone public. One of the more popular sportsbooks in the U.S. is the DraftKings Sportsbook. About two weeks ago, DraftKings went public on the Nasdaq as well.

Although sports betting has hit an all-time low due to the coronavirus pandemic, sports betting companies are still making strides for the industry. Now there are more companies that have gone public on the Nasdaq and more could reasonably do so in the future.

News tags: AIM | Coronavirus | COVID-19 | DraftKings | GAN | Nasdaq | stock market